Search

Displaying results 8301 - 8310 of 10000 in total
  1. Drug

    Casimiroin

    go.drugbank.com/drugs/DB08744
    Experimental

    Casimiroin is a quinone reductase 2 inhibitor isolated from _Casimiroa edulis_.

  2. Drug

    Sonlicromanol

    go.drugbank.com/drugs/DB16333
    Investigational

    Sonlicromanol is under investigation in clinical trial NCT04165239 (The KHENERGYZE Study).

    Synonyms: (S)-6-Hydroxy-2,5,7,8-Tetramethyl-N-((R)-Piperidin-3-Yl)Chroman-2-Carboxamide
  3. Drug

    PIK-75

    go.drugbank.com/drugs/DB17047
    Experimental

    PIK-75 is a preferential p110 alpha/gamma PI3K inhibitor.[A253097]

  4. Drug

    SNX-2112

    go.drugbank.com/drugs/DB17055
    Experimental

    SNX-2112 is a heat shock protein 90 (Hsp90) inhibitor.[A253137]

  5. Drug

    MGD-024

    go.drugbank.com/drugs/DB17265
    Investigational

    MGD-024 is an anti-CD123/anti-CD3 bispecific DART molecule.

  6. Drug

    MEDI-547

    go.drugbank.com/drugs/DB18360
    Investigational

    MEDI-547 is an anti-EphA1 monoclonal antibody conjugated to mcMMAF

  7. Drug

    ISB 1442

    go.drugbank.com/drugs/DB18475
    Investigational

    ISB 1442 is a bispecific, biparatopic antibody targeting CD38 and CD47

  8. Drug

    BCX10013

    go.drugbank.com/drugs/DB18496
    Investigational

    BCX10013 is a small molecule inhibitor of human complement factor D.

  9. Drug

    2G7

    go.drugbank.com/drugs/DB18589
    Experimental

    2G7 is an anti-TGF-beta monoclonal antibody developed by Genentech.

  10. Drug

    GLB-006

    go.drugbank.com/drugs/DB32799
    Experimental

    GLB-006 is a molecular glue degrader targeting NEK7.[L56125, L56126]